Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 21

Results For "Dash"

2621 News Found

Gleneagles hospital performs customised 3D-printed hip reconstruction surgery
Hospitals | May 20, 2026

Gleneagles hospital performs customised 3D-printed hip reconstruction surgery

A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern


Apothecon Pharma appoints Shyamakant Giri as Group CEO
People | May 20, 2026

Apothecon Pharma appoints Shyamakant Giri as Group CEO

In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States


Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates
News | May 20, 2026

Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates

The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform


Philips unveils AI-powered SmartIQ to enhance coronary imaging
Medical Device | May 20, 2026

Philips unveils AI-powered SmartIQ to enhance coronary imaging

New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ


Bayer’s stroke drug wins fast-track review in US
Drug Approval | May 20, 2026

Bayer’s stroke drug wins fast-track review in US

The development comes as stroke remains one of the world’s biggest health threats


MedGenome to expand integrated diagnostics access across Mumbai suburbs
Healthcare | May 19, 2026

MedGenome to expand integrated diagnostics access across Mumbai suburbs

Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets


India’s opportunity to build preventive healthcare economy
Opinion | May 19, 2026

India’s opportunity to build preventive healthcare economy

The country’s strength lies not just in technology availability but in adoption behaviour


HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity
News | May 19, 2026

HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity

Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026